Back to search

University of British Columbia

Blood biomarkers in chronic obstructive pulmonary disease (COPD)

Abstract

dc:description

Chronic obstructive pulmonary disease(COPD) is an age-related disease and demonstrates many biological hallmarks of aging including telomere shortening and epigenetic alterations. This study examined the relationship between telomere length, reflecting replicative senescence, and Alu and LINE-1(L1) methylation, reflecting one of the major epigenetic changes of peripheral blood leukocytes, and clinical outcomes, including lung function, health status, rate of exacerbations, and risk of mortality with different COPD stages. Using quantitative polymerase chain reaction, we measured the absolute telomere length(aTL) of DNA extracted from blood samples of 576 participants with moderate-to-severe COPD treated with either azithromycin or placebo in the Macrolide Azithromycin for Prevention of Exacerbations of COPD(MACRO) study. Using bisulfite pyrosequencing, we measured the percentage(%) Alu and L1 methylation of DNA extracted from blood samples of 495 participants with acute-exacerbating-COPD(AECOPD) in the COPD Rapid Transition Program(RTP), and 373 participants with non-COPD in the Canadian Cohort of Obstructive Lung Disease(CanCOLD). Participants with shorter aTL (defined as below the median cutoff value for aTL) had worse health status as defined by higher St. George’s Respiratory Questionnaire(SGRQ) scores (P=0.034). In the placebo arm, the rate of exacerbations (P=0.002) and the risk of mortality (P=0.015) were significantly higher in the shorter telomere group than in the longer telomere group. % Alu methylation was significantly related to FEV₁% predicted, FEV₁ in liters(L) and FEV₁/FVC ratio (P<0.0001), and when the cohort was divided into quartiles, the higher the quartile the better the FEV1 % predicted and FEV₁(L) (P<0.0001). % Alu methylation was also significantly related to the decline of FEV₁% predicted (%/year), (P=0.004) and FEV₁/FVC ratio (%/year)(P=0.007) as well as to total and sub-domain SGRQ scores (P<0.0001 except the Impact score P=0.041). % L1 methylation was significantly different between different states of COPD: stable-, non- & AE-COPD, where the non-COPD participants had the highest percentage of methylation and AECOPD participants demonstrated the lowest (P<0.0001). Together these data suggest that senescence blood biomarkers in COPD patients are associated with poor health outcomes. These relatively simple blood measurements may represent a potential source of clinically translatable biomarkers for identifying patients at high risk of morbidity and mortality in COPD.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Jin, Minhee

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/71076

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Jin, Minhee. Blood biomarkers in chronic obstructive pulmonary disease (COPD). master's thesis, University of British Columbia, 2019. http://hdl.handle.net/2429/71076